Metabolic factors affect the occurrence of colorectal neoplasm on surveillance colonoscopies

Journal of Gastroenterology and Hepatology (Australia)

Volumn 31, Issue 7, 2016, Pages 1273-1279

  So, Hoonsub ^a   Han, Seungbong ^b   Park, Hye Won ^a   Kim, Eun Hee ^a   Lee, Ji Young ^a   Lee, Ho Su ^a   Chang, Hye Sook ^a   Kim, Hong Kyu ^a   Choe, Jaewon ^a   Park, Sang Hyoung ^a   Yang, Dong Hoon ^a   Myung, Seung Jae ^a   Yang, Suk Kyun ^a   Byeon, Jeong Sik ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Gachon University College of Medicine   (South Korea)

Author keywords

colorectal neoplasm; metabolic syndrome; surveillance; waist circumference

Indexed keywords

ALCOHOL; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LIPID;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; CANCER RISK; CANCER SCREENING; CHOLESTEROL BLOOD LEVEL; COLONOSCOPY; COLORECTAL TUMOR; DRINKING BEHAVIOR; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC PARAMETERS; MIDDLE AGED; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; COLORECTAL NEOPLASMS; DIET RESTRICTION; METABOLISM; PREVALENCE;

ADULT; BLOOD GLUCOSE; C-REACTIVE PROTEIN; COLONOSCOPY; COLORECTAL NEOPLASMS; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LIPIDS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84979608899     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13286     Document Type: Article

References (18)

1. Nishihara R, Wu K, Lochhead P et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N. Engl. J. Med. 2013; 369: 1095–105.
2. Chung SJ, Kim YS, Yang SY et al. Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans. Gut 2011; 60: 1537–43.
3. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012; 143: 844–57.
4. Arditi C, Gonvers JJ, Burnand B et al. Appropriateness of colonoscopy in Europe (EPAGE II). Surveillance after polypectomy and after resection of colorectal cancer. Endoscopy 2009; 41: 209–17.
5. Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640–5.
6. Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut 2013; 62: 933–47.
7. Morita T, Tabata S, Mineshita M, Mizoue T, Moore MA, Kono S. The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study. Asian Pac. J. Cancer Prev. 2005; 6: 485–9.
8. Okabayashi K, Ashrafian H, Hasegawa H et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am. J. Gastroenterol. 2012; 107: 1175–85 quiz 1186.
9. Yang MH, Rampal S, Sung J et al. The association of serum lipids with colorectal adenomas. Am. J. Gastroenterol. 2013; 108: 833–41.
10. Rampal S, Yang MH, Sung J et al. Association between markers of glucose metabolism and risk of colorectal adenoma. Gastroenterology 2014; 147: 78–87. e73.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–9.
12. Kim MK, Lee WY, Kang JH et al. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab (Seoul) 2014; 29: 405–9.
13. Kim JH, Lim YJ, Kim YH et al. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol. Biomarkers Prev. 2007; 16: 1543–6.
14. Oh TH, Byeon JS, Myung SJ et al. Visceral obesity as a risk factor for colorectal neoplasm. J. Gastroenterol. Hepatol. 2008; 23: 411–7.
15. Kang HW, Kim D, Kim HJ et al. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study. Am. J. Gastroenterol. 2010; 105: 178–87.
16. Chiu HM, Lee YC, Tu CH et al. Effects of metabolic syndrome and findings from baseline colonoscopies on occurrence of colorectal neoplasms. Clin. Gastroenterol. Hepatol. 2015; 13: 1134–42.
17. Alberts DS, Martinez ME, Roe DJ et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N. Engl. J. Med. 2000; 342: 1156–62.
18. Colbert LH, Lanza E, Ballard-Barbash R et al. Adenomatous polyp recurrence and physical activity in the Polyp Prevention Trial (United States). Cancer Causes Control 2002; 13: 445–53.